Interstitial Lung Disease With Anti-Melanoma Differentiation-Associated Protein 5 Antibody: Rapidly Progressive Perilobular Opacity

Internal Medicine - Japan
doi 10.2169/internalmedicine.2328-18
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Japanese Society of Internal Medicine

Related search

Rapidly Progressive Interstitial Lung Disease Originating From Clinically Amyopathic Dermatomyositis Associated With Positive Anti-Mda 5 Antibody: A Case Report and Literature Review

SN Comprehensive Clinical Medicine
2019English

Rapidly Progressive Melanoma Differentiation–associated Protein 5–positive Amyopathic Dermatomyositis in an HIV-positive Patient

JAAD Case Reports
Dermatology
2017English

An Unusual Anti–melanoma Differentiation–associated Protein 5 Amyopathic Dermatomyositis

JAAD Case Reports
Dermatology
2019English

Intravenous Immunoglobulin Contributes to Control Anti-Melanoma Differentiation-Associated Protein 5 (MDA5) Antibody-Associated Dermatomyositis With Palmar Violaceous Macules/Papules

British Journal of Dermatology
DermatologyMedicine
2017English

Early Pulmonary Involvement of Anti-Cadm-140 Autoantibody-Positive Rapidly Progressive Interstitial Lung Disease Preceding Typical Cutaneous Symptoms

Internal Medicine
Internal MedicineMedicine
2014English

Anti-Glycyl tRNA Synthetase Antibody Associated Interstitial Lung Disease Without Symptoms of Polymyositis/Dermatomyositis

Pathology International
MedicineForensic MedicinePathology
2014English

Nonspecific Interstitial Pneumonia (NSIP) Associated With Anti-Ks Antibody: Differentiation From Idiopathic NSIP

Internal Medicine
Internal MedicineMedicine
2009English

Dermatomyositis With Rapidly Progressive Interstitial Lung Disease Treated With Rituximab: A Report of 3 Cases in Japan

Internal Medicine
Internal MedicineMedicine
2017English

Anti–melanoma Differentiation–associated Gene 5 Dermatomyositis Complicated by Myopericarditis

JAAD Case Reports
Dermatology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy